INTRODUCTION
Uridine (1) is one of the four basic components of robonucleic acid (RNA). Upon digestion of foods containing RNA, uridine is released from RNA and is absorbed intact in the gut. Uridine is found in sugarcane, tomatos, broccoli, liver, pancreas etc. Uridine has anti depression activity, asthmatic airway inflammation, hepatocyte proliferation 1, 2 . In addition, uridine has been reported to have other physiological actions in animal studies, such as a vasoconstrictive effect in rats, which was reversed by adenosine 3 and hyperpolarized amphibian ganglia and superior cervical ganglia in rats, possibly related to an inhibitory activity 4 . In humans, uridine is administered to reduce the adverse effects of cancer chemotherapy including 5-fluorouracil, such as bone marrow and gastrointestinal toxicity 5 . Furthermore, a combination of uridine and benzylacyclouridine (uridine phosphorylase inhibitor) was shown to reduce neurotoxicity and bone marrow toxicity related to zidovudine used for treatment of HIV infection 6 . However, the physiological activities of uridine in humans remain undetermined.
Nucleotides and nucleosides are key compounds involved in major biological processes, such as nucleic acids and proteins synthesis, cell signaling, enzyme regulation, and metabolism. Indeed, many nucleoside analogues are already clinically used as antiviral 7, 8 and antitumoral agents 9, 10 . However, their efficiency is sometimes reduced by the appearance of resistance mechanisms 11 . The availability of new nucleoside derivatives 12 , therefore, is still of prime importance.
A number of fruitful and efficient methods for selective acylation were reported by many carbohydrate chemists using many acylating agents and varying reaction conditions 13, 14 . However, most of these methods are based on the blocking and deblocking of the hydroxyl groups which are not directly involved in the reaction 15, 16 . Various methods for acylation of carbohydrates and nucleosides have so far been developed and employed successfully [17] [18] [19] . Of these, direct method has been found to be the most encouraging method for acylation of carbohydrates and nucleosides 20 .
From literature survey revealed that a large number of biologically active compounds possess aromatic and heteroaromatic nucleus and acyl substituents 21, 22 . It is also known that, if an active nucleus is linked to another nucleus, the resulting molecule may possess greater potential for biological activity 23 . The benzene and substituted benzene nuclei play important role as common denominator of various biological activities 24 . Results of an ongoing research work on selective acylation of nucleosides 25 and also evaluation of antimicrobial activities reveal that in many cases the combination of two or more aromatic or heteroaromatic nuclei 23 . It is also found that N, S and X containing substitution products showed marked antimicrobial activities i.e., enhance the biological activity of the parent compound 26, 27 . Encouraged by literature reports and our own findings 28, 29 , we synthesized some selectively acylated derivatives of uridine (1) (Scheme 1-2 & Table 1 ) containing various substituents in a single molecular framework and evaluated their antibacterial and antifungal activities using a variety of bacterial and fungal pathogens.
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METHODOLOGY

Chemicals
Melting points were determined on an electro-thermal melting point apparatus (England) and are uncorrected. Evaporations were carried out under reduced pressure using VV-1 type vacuum rotary evaporator (Germany) with a bath temperature below 40 o C. Thin layer chromatography (t.l.c) was performed on
Kieselgel GF 254 and spots were detected by spraying the plates with 1% H 2 SO 4 and heating at 150-200 o C until coloration took place. Column chromatography was performed with silica gel G 60 . All reagents used were commercially available (Aldrich) and were used as received, unless otherwise specified.
Structure and physical properties of uridine derivatives
The structures of newly synthesized compounds were determined through NMR spectroscopy and mass spectrometry. H-NMR spectra (400 MHz) were recorded for solutions in deuteriochloroform (CDCl 3 ) (internal Me 4 Si) with a Bruker DPX-40C spectrometer. Synthesized compounds were also conducted by liquid chromatography electrospray ionization-tandem mass spectrometry in positive ionization mode (LC/ESI(+)-MS/MS) by using a system that consisted of a JASSO LC (JASCO, Tokyo, Japan) at the Yokohama City University, Japan. IR spectra were recorded by KBr disc at the Chemistry Department, University of Chittagong, Bangladesh, with an IR Affinity Fourier Transform Infrared Spectrophotometer (SHIMADZU). The physical properties were de-termined and characterized by melting point and elemental analysis (C and H).
Synthesis of uridine derivatives
5´-O-octanoyluridine (Compound 2)
A solution of the uridine (1) (200 mg, 0.83 mmol) in anhydrous pyridine (3 ml) was cooled to 0 o C when octanoyl chloride (0.3 ml, 1.1 molar eq.) was added.
The reaction mixture was continuously stirred for 6 hours at 0 0 C temperature and then the reaction mixture was standing for overnight at room temperature with continuous stirring. The progress of the reaction was monitored by t.l.c (methanol-chloroform, 1:24) which indicated full conversion of the starting material into a single product (R f = 0.50). The solution was poured into ice water with constant stirring. It was then extracted with chloroform (3×10 ml). The combined chloroform layer was washed successively with dilute hydrochloric acid, saturated aqueous sodium hydrogen carbonate solution and distilled water. The organic layer was dried (Na 2 SO 4 ), filtered and concentrated. The organic layer was dried (MgSO 4 ), filtered and concentrated. Purification by chromatography with methanol-chloroform (1:24) as eluant and furnished the octanoyl chloride derivative (2) (164 mg, 82%) as solid mass, which was used in the next stage. Physical properties are shown in the 
General procedure for synthesis of 5´-O-octanoyl derivatives
A cooled (0 0 C) and stirred solution of compound (2) (120.8 mg, 0.33 mmol) in dry pyridine (3 ml) was treated with 5 molar equivalents of pentanoyl chloride (0.14 ml, 5.1 mmol) and the solution was left standing overnight in the room temperature. The progress of the reaction was monitored by t.l.c (methanolchloroform, 1:18) which indicated the complete conversion of the starting material into faster moving product (R f = 0.54). Aqueous work-up procedure as described earlier and silica gel column chromatographic purification (methanol-chloroform, 1:18 as eluant), gave the pentanoylate (3) (110 mg, 91%) as a pasty mass.
Using the similar reaction procedure, compound 3 was converted to compound 4, 5, 6, 7, 8, 9, 10, 11, 12 and compound 13. 
5´-O-
2´,3´-Di-O-hexanoyl-5´-O-octanoyluridine (Compound 4)
Colour: white, solubility: CHCl 3 , DMF, DMSO. FTIR (KBr) ν max (cm 
2´,3´-Di-O-decanoyl-5´-O-octanoyluridine (Compound 5)
Colour: dark white, solubility: CHCl 3 , DMF, DMSO. FTIR (KBr) ν max (cm 
2´,3´-Di-O-myristoyl-5´-O-octanoyluridine (Compound 7)
Colour: deep white, solubility: CHCl 3 , DMF, DMSO. FTIR (KBr) ν max (cm 
2´,3´-Di-O-benzenesulfonyl-5´-O-octanoyluridine (Compound 11)
Colour: light white, solubility: CHCl 3 , DMF, DMSO. FTIR (KBr) ν max (cm 
Microbial screening studies
Test tube cultures of bacterial pathogens were obtained from the Microbiology Laboratory, Department of Microbiology, University of Chittagong. The synthesized test compounds (Table 2 & 3) were subjected to antibacterial screening against three Gram-positive and three Gram-negative bacterial strains ( Table 1) .
Preparation of bacterial suspension
About 10 ml of distilled water was taken in a clean screw cap test tube. A number of test tubes with water were sterilized in an autoclave. From 48 hours; old bacterial culture, one loop of bacterial culture was transferred to the sterilized distilled water and mixed it properly. These bacterial suspensions of the test tube were used to the pour plate during sensitivity test. Table 1 . List of used bacteria and fungus.
Types of organisms Tested organisms & strain no.
Bacteria
Gram +Ve
Bacillus subtilis BTCC 17
Bacillus cereus BTCC 19
Gram -Ve
Escherichia coli ATCC 25922
Pseudomonas aeruginosa ICDDR,B
Salmonella typhi AE 14612
Fungus
Aspergillus niger ATCC 16404
Rhizopous nigricans ATCC 6227b
Antibacterial efficacy test
The in vitro antibacterial activities of the synthesized chemicals were detected by disc diffusion method 30, 31 . Paper discs of 4 mm in diameter and glass petri plate of 90 mm in diameter were used throughout the experiment. Paper discs were sterilized in an autoclave and dried at 100 0 C in an oven. Then the discs were soaked with test chemicals at the rate of 50µg (dry weight) per disc for antibacterial analysis. For pour plate technique, one drop of bacterial suspension was taken in a sterile petri dish and approximately 20 ml of melted sterile nutrient agar (NA) (~45 0 C) was poured into the plate, and then mixed thoroughly with the direction of clockwise and anticlockwise. After solidification of the seeded NA medium, paper disc after soaking with test chemicals (2% in CHCl 3 ) were placed at the centre of the inoculated petri dish. A control plate was also maintained in each case with chloroform. Firstly, the plates were kept for 4 hrs. at low temperature (4 0 C) and the test chemicals diffused from disc to the surrounding medium by this time. The plates were then incubated at (35± 2) 0 C for growth of test organisms and were observed at 24 hrs. intervals for two days. The activity was expressed in terms of inhibition zone diameter in mm. Each experiment was repeated thrice. The standard antibiotic Ampicillin from FISONS Ltd. (Bangladesh) was used as a positive control and compared with tested chemicals under identical conditions.
Antifungal efficacy test
The in vitro antifungal functionality tests of the synthesized chemicals were tested by mycelial growth test 32 . Required amount of medium was taken in a conical flask separately and was sterilized in autoclave. After autoclaving, weighted amount of test chemicals (2%) was added to the sterilized medium in conical flask at the point of pouring to obtain the desired concentration. The flask was shaken thoroughly to mix the chemical with the medium homogeneously before pouring. The medium with definite concentration (2%) of chemical was poured at the rate of 10 µl in sterilized glass Petri dishes individually. Proper control was maintained separately with sterilized PDA (potato dextrose agar) medium without chemicals and three replications were prepared for each treatment. After solidification of medium, the fungal inoculums (5 mm approximately) were placed at the centre of each Petri dish in an inverted position. All the plates were inoculated at room temperature on the laboratory desk for five days. The linear growth of fungal colony was measured in two directions at right angle to each other after five days of incubation and average of three replicates was taken as the diameter of a colony in mm. The percentage inhibition of mycelial growth of test fungi was calculated as follow:
after five days of incubation and average of three replicates was taken as the diameter of a colony in mm. The percentage inhibition of mycelial growth of test fungi was calculated as follow:
Where, I = percentage of inhibition, C = diameter of the fungal colony in control, T = diameter of the fungal colony in treatment. The antifungal results were compared with that of the standard antibiotic Nystatin (100 µg dw./disc, BEXIMCO Pharm. Bangladesh Ltd.). 
Compounds
Name of the tested compounds Molecular formula
Where, I = percentage of inhibition, C = diameter of the fungal colony in control, T = diameter of the fungal colony in treatment. The antifungal results were compared with that of the standard antibiotic, Nystatin (100 µg dw./disc, BEXIMCO Pharm. Bangladesh Ltd.). 
RESULTS AND DISCUSSION
Synthesis and characterization
In the present investigation, we carried out selective octanoylation of of uridine (1) with octanoyl chloride using the direct acylation method (Scheme 1-2 & Table 3 & 4) . A series of derivatives of the resulting acylation products were prepared in order to gather supportive evidences for structure elucidation and also to obtain newer derivatives of synthetic and biological importance.
Our initial effort was to carry out selective acylation of uridine (1) with unimolecular amount of non-traditional acylating agent octanoyl chloride in dry pyridine at -5 0 C. Conventional work-up procedure, followed by removal of solvent and silica gel column chromatographic purification, we obtained the octanoyl derivative (2). This compound (2) was sufficiently pure for use in the next reactions. The IR spectrum of this compound showed the following characteristic peaks: 1728 (-CO) and 3358-3520 cm-1 (br -OH stretching). In its 1 H-NMR spectrum, two two-proton multiplets at δ 2.34 {CH 3 (CH 2 ) 5 CH 2 CO-} and 1.61 {CH 3 (CH 2 ) 4 CH 2 CH 2 CO-}, an eight-proton multiplet at δ 1.26 {CH 3 (CH 2 ) 4 (CH 2 ) 2 CO-} and a three-proton multiplet at δ 0.87 {CH 3 (CH 2 ) 6 CO-} were due to the one octanoyl group, thereby suggesting the introduction of one octanoyl group in the molecule. In addition, confirmation of the structure accorded to compound (2) was achieved by its conversion to and identification by Thus, selective octanoylation of uridine (1) was successfully carried out using the direct acylation method. A single, monosubstitution product was isolated pure in each case in reasonably high yields. The octanoyl derivative was further transformed into its different acyl derivatives. These transformations were conducted in order to gather supportive evidences for elucidating structures of the parent acylation products and also to obtain new products of synthetic and biological importance. All these newly synthesized products (Table 3) may be employed as important precursors for the modification of the uridine (1) molecule at different positions.
Screening of microbial efficacy
From the experimental results obtained by using a number of selected human pathogenic bacteria (as shown in Figure 2 , 3 & 5) were found that selectively acylated uridine derivatives 10, 11 and 13 showed good inhibition against Gram-positive bacteria while compounds 10 and 13 were also very active against Gram-negative bacteria. We also observed that some compounds such as 10 and 13 are highly active against both the Gram-positive and Gram-negative organisms. So, these compounds may be targeted for future studies for their usage as broad spectrum antibiotics. In general, it has been observed that antibacterial results of the selectively acylated uridine derivatives obtained by using various acylating agents follow the order for Gram-positive organisms: 10 > 13> 9 > 11 = 3 > 4 > 5 >12 = 7 and Gram-negative bacteria follow the order: 10 > 13 = 11 > 6= 4 > 5 > 9. From this study we found that among the acylated products, compound 10 showed effective activities (17 mm) against both B. subtilis & E. coli and compounds 13 (16 mm) and 10 (15 mm) showed high activity against the E. coli and P. aeruginosa microorganisms, respectively. Some of the tested chemicals showed moderate to marked inhibition against the bacterial pathogens employed. It was also found that some tested chemicals were unable to show any inhibition at all against the bacterial pathogens employed. It was also observed that the uridine derivatives were found comparatively more effective against Gram-positive bacteria than that of Gram-negative bacteria.
The results obtained from the present investigation of antifungal studies mentioned in Figure 4 and 6 clearly demonstrate that compounds 5 showed the highest inhibition (60.0%) against the Rhizopers nigricans. Excellent inhibition was observed in case of compound 10 (55.0%) in which the percent inhibi tion is very close to the standard antibiotic Nystatin against Aspergillus niger. Compounds 4 (50.0%) and 13 (50.0%) showed the good inhibition against the Aspergillus niger and Rhizopers nigricans, respectively. However, most of the compounds showed to be less active or toxic to the selected plant pathogens as compared to the standard antibiotic (Nystatin). So, it was found that the newly synthesized and reported compounds 5 and 10 were very much effective against both fungal strains. These antimicrobial efficacies of our tested compounds were in accordance with the results we observed before 34, 35 . The brine shrimp lethality assay is considered a useful tool for assessment of toxicity. The cytotoxic activity of the acylated derivatives of uridine (Scheme 1, 2, Table 1 ) in the brine shrimp lethality bioassay showed different rate mortality with different concentrations. It is expected that this piece of work employing uridine derivatives as test compounds will open the scope for further work on the development of pesticides and medicines sectors.
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CONCLUSION
The synthesized uridine derivatives have shown promising antibacterial and antifungal activities. Out of twelve active compounds, three of them (5, 10 and 15) have shown very good antimicrobial inhibiting activity. However, these three compounds have also shown significant cytotoxic activity against brine shrimp lethality assay. Therefore, it is expected that the newly acylated uridine derivatives might show potential antiviral, antidiabetic, anticancer and antiinflammatory activities.
